P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

Cervera, J.; Solé, F.; Haase, D.; Luño, E.; Such, E.; Nomdedeu, B.; Costa, D.; Bernal, T.; Vallespí, T.; Bueno, J.; Pedro, C.; Mallo, M.; Ardanaz, M. T.; Calasanz, M. J.; del Cañizo, C.; Hernández-Rivas, J. M.; Schanz, J.; Steidl, C.; Hildebrandt, B.; Carbonell, F.; Orero, M.; Ramos, F.; Marco, V.; Tormo, M.; Gomez, V.; Andreu, R.; Xicoy, B.; Amigo, M. L.; Muñoz, J. A.; Bonanad, S.; Arrizabalaga, B.; Senent, M. L.; Germing, U.; Sanz, G. F.

Published in

Elsevier, Leukemia Research, (33), p. S75-S76

DOI: 10.1016/s0145-2126(09)70110-9

Tools

Export citation

Search in Google Scholar

P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

Journal article published in 2009 by J. Cervera, F. Solé, D. Haase, E. Luño, E. Such, B. Nomdedeu, D. Costa, T. Bernal, T. Vallespí, J. Bueno, C. Pedro, M. Mallo, M. T. Ardanaz, M. J. Calasanz, C. del Cañizo and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)